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Background
Normal pressure hydrocephalus has increasingly been rec-
ognized as a cause of reversible gait disorder, dementia,
and incontinence; however, unlike paediatric hydroceph-
alus the longevity of shunt survival and complications are
poorly documented.
Materials and methods
Retrospective chart review was conducted on normal pres-
sure hydrocephalus patients who received prospective
evaluation at an adult hydrocephalus center and under-
went ventriculoperitoneal or ventriculoatrial shunting
with either Delta 1 (n = 140) or Orbis Sigma (n = 55)
valves between September 1999 and June 2007. All
patients received treatment and follow-up from a single
surgeon. Time until first revision, time until first subdural
hematoma requiring intervention, death – confirmed by
the social security death index – and clinical outcome
were assessed.
Results
As a group of 195 patients, the mean and median age at
time of surgery was 77.5 years, with a standard deviation
of 7.0 years. At the end of the first year 8% of patients had
expired, and at the end of five years post-shunt 47 patients
or 27% of the patient population had expired. Age was an
independent predictor of death associated with an Odds
Ratio of 1.05 (p = 0.046). At one year post-shunt, 16%
patients required distal revision and at five years 24% of
patients required distal revision; 58% of distal malfunc-
tions occurred in the first post-operative year. Nineteen
subdurals were associated with this group and occurred
early post-operatively – 17 subdurals (90%) occurred
within the first 90 days. The incidence of subdurals in the
OSV group was associated with an Odd Ratio of 2.95 (p =
0.026) as compared to the D1 group. Additionally, age
was also an independent predictor of SDH with an Odd
Ratio of 1.11 (p = 0.009). Initial clinical improvement
maybe associated increased patient survival. Unfortu-
nately due to the relatively small population size and sta-
tistical power considerations these results are still
tentative (p = 0.15). Six shunt infections occurred, yield-
ing a 3% rate of infection.
Individual analysis of the Delta 1 and Orbis Sigma valves
with Kaplan-Meier estimates show no statistical signifi-
cant differences in 5-year patient survival, incidence of
distal occlusions, or clinical outcome; however with
regard to the occurrence of subdurals, increased age and
the Orbis Sigma were associated with a significant
increase in occurrence.
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Evaluation of these 195 patients has given a clearer picture
as to the longevity of shunts in normal pressure hydro-
cephalus. Further evaluation is still necessary to determine
how other clinical factors may have possible effects on
shunt survival and outcomes in these patients.Page 2 of 2
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